Blog
RSS FeedPosted by Michael Wonder on 30 Apr 2018
Brexit diagnosis predicts drug delay for UK patients
28 April 2018 - One of Scotland’s leading neurologists has warned that Brexit will delay the newest life-saving drugs reaching ...
Posted by Michael Wonder on 17 Apr 2018
Governments must speed up access to approved cancer drugs
16 April 2018 - Strides in cancer research have increased survival rates and provided a better quality of life for ...
Posted by Michael Wonder on 07 Apr 2018
New drugs: patients are needlessly waiting 15 months too long
5 April 2018 - Regulatory obstacles entail an additional delay of 15 months on average between the moment when a ...
Posted by Michael Wonder on 12 Dec 2017
Cancer patients in New Zealand waiting months for treatment as hospitals struggle to cope
13 December 2017 - Cancer patients around the country are waiting months to receive their first bout of potentially life-saving ...
Posted by Michael Wonder on 05 Dec 2017
How giving private patients priority in public hospitals is pushing up health fund premiums
6 December 2017 - Privately insured patients are jumping the queues for surgery in public hospitals and getting treated twice ...
Posted by Michael Wonder on 04 Dec 2017
Brexit may mean British patients have to wait longer for life-saving drugs with the NHS forced to shell out more for them, pharmaceutical bosses warn
3 December 2017 - Pharmaceutical boss Mark Hicken was addressing the House of Lords last week. ...
Posted by Michael Wonder on 02 Dec 2017
Accelerated access to new drugs and technologies
22 November 2017 - UK government’s proposed scheme is unlikely to improve patient outcomes. ...
Posted by Michael Wonder on 20 Nov 2017
Push to speed up access to treatment for cancer patients
21 November 2017 - Australian cancer patients are waiting twice as long those overseas to get access to life saving ...
Posted by Michael Wonder on 14 Nov 2017
NICE to play key role in UK drug fast-track scheme
14 November 2017 - NICE has been chosen to run the office that will decide which ground-breaking healthcare products will ...
Posted by Michael Wonder on 03 Nov 2017
ICR responds to Government report produced following Accelerated Access Review
3 November 2017 - The Institute of Cancer Research, London, today responds to the Government’s announcement of a new, fast-track ...
Posted by Michael Wonder on 03 Nov 2017
NHS patients to get faster access to 'breakthrough' medicines
3 November 2017 - Drug firms will be offered a fast-track route to get “breakthrough” medicines to NHS patients up ...
Posted by Michael Wonder on 26 Sep 2017
TGA and PBAC parallel process now available for vaccines
26 September 2017 - Vaccines that meet certain requirements are now eligible to be submitted under the TGA and PBAC ...
Posted by Michael Wonder on 29 Jul 2017
‘It’s very frustrating’: ovarian cancer patient waiting on potential approval of new treatment
27 July 2017 - Seventy-five women are diagnosed with ovarian cancer in Saskatchewan each year, and fifty-five lose their lives. ...
Posted by Michael Wonder on 15 Jul 2017
Disappointment as government delays pharma-friendly policies
14 July 2017 - The government’s Accelerated Access Review was supposed to herald a new age of innovation in the ...
Posted by Michael Wonder on 06 Apr 2017
Pharma warns new NICE rules will delay access to medicines
3 April 2017 - Pharma companies are warning that changes to the way the National Institute for Health & Care ...